Article Text

PDF
Redefining the clinical phenotypes of non-dystrophic myotonic syndromes
  1. J Trip1,2,
  2. G Drost2,
  3. H B Ginjaar3,
  4. F H M Nieman4,
  5. A J van der Kooi5,
  6. M de Visser5,
  7. B G M van Engelen2,
  8. C G Faber1
  1. 1
    Department of Neurology, Maastricht University Medical Centre, Maastricht, The Netherlands
  2. 2
    Neuromuscular Centre Nijmegen, Department of Neurology, Radboud University Nijmegen, Medical Centre, Nijmegen, The Netherlands
  3. 3
    Department of Human and Clinical Genetics, Leiden University Medical Centre, Leiden, The Netherlands
  4. 4
    Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Centre, Maastricht, The Netherlands
  5. 5
    Department of Neurology, Academic Medical Centre University of Amsterdam, Amsterdam, The Netherlands
  1. Dr J Trip, Maastricht University Medical Centre, Department of Neurology, PO Box 5800, 6202 AZ Maastricht, The Netherlands; jeroen.trip{at}online.nl

Abstract

Objective: To redefine phenotypical characteristics for both chloride (ClCh) and sodium channelopathies (NaCh) in non-dystrophic myotonic syndromes (NDM).

Methods: In a cross-sectional, nationwide study, standardised interviews and clinical bedside tests were performed in 62 genetically confirmed NDM patients, 32 ClCh and 30 NaCh.

Results: Standardised interviews revealed that ClCh reported a higher frequency of muscle weakness (75 vs 36.7%; p<0.01), the warm-up phenomenon (100 vs 46.7%; p<0.001), and difficulties in standing up quickly (90.6 vs 50.0%; p<0.001), running (90.6% vs 66.7; p<0.05) and climbing stairs (90.6 vs 63.3%; p = 0.01). Patients with NaCh reported an earlier onset (4.4 vs 9.6 years; p<0.001), and higher frequencies of paradoxical (50.0 vs 0%; p<0.001) and painful myotonia (56.7 vs 28.1%; p<0.05). Standardised clinical bedside tests showed a higher incidence and longer relaxation times of myotonia in the leg muscles for ClCh (100 vs 60%; mean duration of chair tests 12.5 vs 6.3 s; p<0.001), and in eyelid muscles for NaCh (96.7 vs 46.9%; mean relaxation time of 19.2 vs 4.3 s; p<0.001). Transient paresis was only observed in ClCh (62.5%) and paradoxical myotonia only in NaCh (30.0%). Multivariate logistic regression analyses allowed clinical guidelines to be proposed for genetic testing.

Conclusion: This study redefined the phenotypical characteristics of NDM in both ClCh and NaCh. The clinical guidelines proposed may help clinicians working in outpatient clinics to perform a focused genetic analysis of either CLCN1 or SCN4A.

Statistics from Altmetric.com

Footnotes

  • Funding: The work reported was supported by a research grant (Mar04-0118) from the “Prinses Beatrix Fonds,” The Hague, The Netherlands.

  • Competing interests: None.

  • Ethics approval: Ethics approval was provided by the medical ethics committee of the Radboud University Nijmegen Medical Centre.

  • Patient consent: Obtained.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.